Redfund Capital Corporation (CSE:LOAN) (Redfund or the “Company”) reflects on the positive impacts on the Company of the United States election results.

Redfund Capital is focused on funding Medical Cannabis, THC-free CBD and HEMP related companies. The Company considers the recent USA increase in individual states approving the prescription of medical cannabis to patients a major milestone for the industry and in turn, for Redfunds portfolio of clients who lead the global cannabis health initiative. Redfund looks forward to medical practitioners having the ability to prescribe once taboo cannabis medicines in more jurisdictions, thus bringing attention to medically beneficial usages.

The USA midterm elections passed medical cannabis ballot proposals in two states this week, including legalized recreational pot in Michigan.  Voters in the states of Utah and Missouri decided patients should have access to medical marijuana and joined many other American states with the adoption of comprehensive medical marijuana programs, making it 33 states plus the territories of Guam, Puerto Rico, and the Northern Mariana Islands and the District of Columbia with some level of ability to prescribe cannabis for specific conditions.

Novel cannabis delivery systems like the disruptive cannabis infusion technology of Biolog Inc. will gain large traction throughout the USA; Biolog Inc. funded by Redfund and press released by the Company September 26th, 2018. Products like that of RxMM Health Care’s Alzheimer’s Defense, a proprietary, CBD-infused all-natural nutraceutical product will increase sales across the country with more exposure in the medical communities; RxMM funded and press released by the Company October 9th, 2018.

An ever-increasing number of patients worldwide are using cannabis for therapeutic reasons. On November 1st the UK proclaimed acceptance of medical cannabis prescribed by neurologists and specialized physicians who joined the global community by pushing medical marijuana forward into the European mainstream. By example, Redfund portfolio client Mary’s Wellness teas, a product which Redfund will assist in creating a brand new presence in the UK as a medicinal option, is a fine example of our continuing drive to expand the portfolio. Mary’s Wellness teas was funded and press released on October 22nd, 2018.

“The Company’s vision is to help our portfolio companies expand their sales beyond country borders. We believe the midterm elections are a positive sign to all of us that the United States will mainstream medical cannabis in the very near future and we look forward to expanding into markets supporting these initiatives,” stated Meris Kott, CEO.

About Redfund Capital Inc.

Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company’s development or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related and healthcare-related companies.

For further information please visit For more information on Redfund Capital contact Meris Kott CEO 604.484.8989 0r

Further information about the Company is available on under the Company’s profile.

 Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Click here to connect with Redfund Capital Corporation (CSE:LOAN) for an Investor Presentation. 


As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.

For more information regarding the Company or the offering, please contact, or

Keep reading... Show less